Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5229 | 1653 | 37.4 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
1516 | 2 | DEXMEDETOMIDINE//AGMATINE//IMIDAZOLINE RECEPTORS | 7504 |
5229 | 1 | AGMATINE//IMIDAZOLINE RECEPTORS//MOXONIDINE | 1653 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AGMATINE | authKW | 4525831 | 21% | 72% | 339 |
2 | IMIDAZOLINE RECEPTORS | authKW | 3540193 | 14% | 83% | 230 |
3 | MOXONIDINE | authKW | 2358855 | 10% | 76% | 168 |
4 | RILMENIDINE | authKW | 1767489 | 7% | 79% | 121 |
5 | IMIDAZOLINE BINDING SITES | authKW | 597092 | 2% | 79% | 41 |
6 | I 1 IMIDAZOLINE RECEPTOR | authKW | 394042 | 1% | 89% | 24 |
7 | IMIDAZOLINE I 2 RECEPTOR | authKW | 372494 | 1% | 92% | 22 |
8 | H 3 IDAZOXAN | authKW | 370257 | 1% | 95% | 21 |
9 | IMIDAZOLINE I 1 RECEPTOR | authKW | 317521 | 1% | 90% | 19 |
10 | 2 BFI | authKW | 314977 | 1% | 95% | 18 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 12675 | 51% | 0% | 843 |
2 | Neurosciences | 2758 | 25% | 0% | 418 |
3 | Peripheral Vascular Diseases | 847 | 7% | 0% | 121 |
4 | Cardiac & Cardiovascular System | 527 | 8% | 0% | 136 |
5 | Chemistry, Medicinal | 252 | 4% | 0% | 73 |
6 | Behavioral Sciences | 175 | 3% | 0% | 46 |
7 | Medicine, Research & Experimental | 123 | 4% | 0% | 73 |
8 | Biochemistry & Molecular Biology | 112 | 12% | 0% | 192 |
9 | Psychiatry | 63 | 3% | 0% | 56 |
10 | Physiology | 47 | 3% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROBIOL PHARMACOL CARDIOVASC | 306016 | 2% | 53% | 31 |
2 | PHARMACOL CARDIOVASC RENALE | 59106 | 0% | 80% | 4 |
3 | PSYCHOPHARMACOL UNIT | 55166 | 2% | 7% | 40 |
4 | NURSING BIOTECHNOL | 41558 | 0% | 75% | 3 |
5 | CSIC NEUROPHARMACOL | 36942 | 0% | 100% | 2 |
6 | DRUG DEPENDENCE CHINA | 36942 | 0% | 100% | 2 |
7 | MEDPHARMACOL CARDIOVASC RENALE CNRS | 36942 | 0% | 100% | 2 |
8 | NEUROPHARMACOL ASSOCIATE UNITCSIC | 36942 | 0% | 100% | 2 |
9 | URA 589 | 36942 | 0% | 100% | 2 |
10 | ASSOCIATE UNIT NEUROPHARMACOL | 24627 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF PHARMACOLOGY | 11877 | 8% | 0% | 135 |
2 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 5579 | 3% | 1% | 43 |
3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 5381 | 3% | 1% | 57 |
4 | REVIEWS IN CONTEMPORARY PHARMACOTHERAPY | 5179 | 0% | 6% | 5 |
5 | BRITISH JOURNAL OF PHARMACOLOGY | 5163 | 4% | 0% | 71 |
6 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 4262 | 6% | 0% | 97 |
7 | JOURNAL OF HYPERTENSION | 3638 | 3% | 0% | 44 |
8 | JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM | 2530 | 1% | 1% | 18 |
9 | PHILOSOPHIA-INTERNATIONAL JOURNAL OF PHILOSOPHY | 2307 | 0% | 13% | 1 |
10 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2206 | 3% | 0% | 51 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AGMATINE | 4525831 | 21% | 72% | 339 | Search AGMATINE | Search AGMATINE |
2 | IMIDAZOLINE RECEPTORS | 3540193 | 14% | 83% | 230 | Search IMIDAZOLINE+RECEPTORS | Search IMIDAZOLINE+RECEPTORS |
3 | MOXONIDINE | 2358855 | 10% | 76% | 168 | Search MOXONIDINE | Search MOXONIDINE |
4 | RILMENIDINE | 1767489 | 7% | 79% | 121 | Search RILMENIDINE | Search RILMENIDINE |
5 | IMIDAZOLINE BINDING SITES | 597092 | 2% | 79% | 41 | Search IMIDAZOLINE+BINDING+SITES | Search IMIDAZOLINE+BINDING+SITES |
6 | I 1 IMIDAZOLINE RECEPTOR | 394042 | 1% | 89% | 24 | Search I+1+IMIDAZOLINE+RECEPTOR | Search I+1+IMIDAZOLINE+RECEPTOR |
7 | IMIDAZOLINE I 2 RECEPTOR | 372494 | 1% | 92% | 22 | Search IMIDAZOLINE+I+2+RECEPTOR | Search IMIDAZOLINE+I+2+RECEPTOR |
8 | H 3 IDAZOXAN | 370257 | 1% | 95% | 21 | Search H+3+IDAZOXAN | Search H+3+IDAZOXAN |
9 | IMIDAZOLINE I 1 RECEPTOR | 317521 | 1% | 90% | 19 | Search IMIDAZOLINE+I+1+RECEPTOR | Search IMIDAZOLINE+I+1+RECEPTOR |
10 | 2 BFI | 314977 | 1% | 95% | 18 | Search 2+BFI | Search 2+BFI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOLDERINGS, GJ , HAENISCH, B , (2012) AGMATINE (DECARBOXYLATED L-ARGININE): PHYSIOLOGICAL ROLE AND THERAPEUTIC POTENTIAL.PHARMACOLOGY & THERAPEUTICS. VOL. 133. ISSUE 3. P. 351 -365 | 215 | 86% | 35 |
2 | PILETZ, JE , ARICIOGLU, F , CHENG, JT , FAIRBANKS, CA , GILAD, VH , HAENISCH, B , HALARIS, A , HONG, S , LEE, JE , LI, J , ET AL (2013) AGMATINE: CLINICAL APPLICATIONS AFTER 100 YEARS IN TRANSLATION.DRUG DISCOVERY TODAY. VOL. 18. ISSUE 17-18. P. 880 -893 | 105 | 90% | 35 |
3 | RAASCH, W , SCHAFER, U , CHUN, J , DOMINIAK, P , (2001) BIOLOGICAL SIGNIFICANCE OF AGMATINE, AN ENDOGENOUS LIGAND AT IMIDAZOLINE BINDING SITES.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 133. ISSUE 6. P. 755-780 | 163 | 68% | 120 |
4 | FARSANG, C , KAPOCSI, J , (1999) IMIDAZOLINE RECEPTORS: FROM DISCOVERY TO ANTIHYPERTENSIVE THERAPY (FACTS AND DOUBTS).BRAIN RESEARCH BULLETIN. VOL. 49. ISSUE 5. P. 317 -331 | 151 | 79% | 38 |
5 | NIKOLIC, K , AGBABA, D , (2012) PHARMACOPHORE DEVELOPMENT AND SAR STUDIES OF IMIDAZOLINE RECEPTOR LIGANDS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 14. P. 1542-1555 | 102 | 77% | 10 |
6 | HALARIS, A , PLIETZ, J , (2007) AGMATINE: METABOLIC PATHWAY AND SPECTRUM OF ACTIVITY IN BRAIN.CNS DRUGS. VOL. 21. ISSUE 11. P. 885 -900 | 80 | 89% | 123 |
7 | KELLER, B , GARCIA-SEVILLA, JA , (2015) IMMUNODETECTION AND SUBCELLULAR DISTRIBUTION OF IMIDAZOLINE RECEPTOR PROTEINS WITH THREE ANTIBODIES IN MOUSE AND HUMAN BRAINS: EFFECTS OF TREATMENTS WITH I-1- AND I-2-IMIDAZOLINE DRUGS.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 29. ISSUE 9. P. 996 -1012 | 72 | 91% | 1 |
8 | NIKOLIC, K , AGBABA, D , (2012) IMIDAZOLINE RECEPTORS LIGANDS.HEMIJSKA INDUSTRIJA. VOL. 66. ISSUE 5. P. 619-635 | 92 | 77% | 0 |
9 | REGUNATHAN, S , REIS, DJ , (1996) IMIDAZOLINE RECEPTORS AND THEIR ENDOGENOUS LIGANDS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 36. ISSUE . P. 511-544 | 110 | 80% | 171 |
10 | NIKOLIC, K , AGBABA, D , (2012) IMIDAZOLINE ANTIHYPERTENSIVE DRUGS: SELECTIVE I1-IMIDAZOLINE RECEPTORS ACTIVATION.CARDIOVASCULAR THERAPEUTICS. VOL. 30. ISSUE 4. P. 209-216 | 75 | 86% | 14 |
Classes with closest relation at Level 1 |